(S)-colchicine increases expression EXP 6480464 Colchicine results in increased expression of FCGR2B mRNA CTD PMID:20624997 1,1,1-trichloro-2,2-bis(4-hydroxyphenyl)ethane affects expression EXP 6480464 2 more ... CTD PMID:19414516 1,1-dichloroethene increases expression ISO RGD:1332447 6480464 vinylidene chloride results in increased expression of FCGR2B mRNA CTD PMID:26682919 1,2,4-trimethylbenzene increases expression EXP 6480464 pseudocumene results in increased expression of FCGR2B protein CTD PMID:17337753 1,2-dimethylhydrazine increases expression ISO RGD:1332447 6480464 1, 2-Dimethylhydrazine results in increased expression of FCGR2B mRNA CTD PMID:22206623 17alpha-ethynylestradiol increases expression EXP 6480464 Ethinyl Estradiol results in increased expression of FCGR2B mRNA CTD PMID:15834898 , PMID:17351261 17beta-estradiol increases expression ISO RGD:1332447 6480464 Estradiol results in increased expression of FCGR2B mRNA CTD PMID:19484750 17beta-estradiol multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FCGR2B mRNA CTD PMID:32741896 17beta-estradiol 3-benzoate multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FCGR2B mRNA CTD PMID:32741896 2,2',4,4',5,5'-hexachlorobiphenyl decreases expression ISO RGD:1346227 6480464 2 more ... CTD PMID:23146750 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1332447 6480464 Tetrachlorodibenzodioxin results in increased expression of FCGR2B mRNA CTD PMID:21041162 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of FCGR2B mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine affects expression EXP 6480464 Tetrachlorodibenzodioxin affects the expression of FCGR2B mRNA CTD PMID:34747641 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:1346227 6480464 Trinitrobenzenesulfonic Acid results in increased expression of FCGR2B mRNA CTD PMID:19524605 2,6-dinitrotoluene affects expression EXP 6480464 2, 6-dinitrotoluene affects the expression of FCGR2B mRNA CTD PMID:21346803 3-phenylprop-2-enal increases expression ISO RGD:1346227 6480464 cinnamaldehyde results in increased expression of FCGR2B mRNA CTD PMID:19524605 3H-1,2-dithiole-3-thione decreases expression EXP 6480464 1, 2-dithiol-3-thione results in decreased expression of FCGR2B mRNA CTD PMID:19162173 4,4'-diaminodiphenylmethane increases expression ISO RGD:1332447 6480464 4, 4'-diaminodiphenylmethane results in increased expression of FCGR2B mRNA CTD PMID:18648102 4,4'-sulfonyldiphenol increases expression ISO RGD:1332447 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of FCGR2B mRNA CTD PMID:30951980 4,4'-sulfonyldiphenol decreases expression ISO RGD:1332447 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of FCGR2B mRNA CTD PMID:33297965 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO RGD:1346227 6480464 Oxazolone results in increased expression of FCGR2B mRNA CTD PMID:17374397 4-hydroxynon-2-enal decreases expression ISO RGD:1332447 6480464 4-hydroxy-2-nonenal results in decreased expression of FCGR2B mRNA CTD PMID:19191707 4-hydroxyphenyl retinamide decreases expression ISO RGD:1332447 6480464 Fenretinide results in decreased expression of FCGR2B mRNA CTD PMID:28973697 6-propyl-2-thiouracil increases expression EXP 6480464 Propylthiouracil results in increased expression of FCGR2B mRNA CTD PMID:24780913 acetamide increases expression EXP 6480464 acetamide results in increased expression of FCGR2B mRNA CTD PMID:31881176 all-trans-retinoic acid affects expression ISO RGD:1346227 6480464 Tretinoin affects the expression of FCGR2B mRNA CTD PMID:15498508 all-trans-retinoic acid increases expression ISO RGD:1346227 6480464 Tretinoin results in increased expression of FCGR2B mRNA CTD PMID:15894607 , PMID:33167477 amiodarone increases expression EXP 6480464 Amiodarone results in increased expression of FCGR2B mRNA CTD PMID:25580480 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of FCGR2B mRNA CTD PMID:16483693 amphetamine increases expression EXP 6480464 Amphetamine results in increased expression of FCGR2B mRNA CTD PMID:30779732 antirheumatic drug decreases expression ISO RGD:1346227 6480464 Antirheumatic Agents results in decreased expression of FCGR2B mRNA CTD PMID:24449571 benzo[a]pyrene multiple interactions ISO RGD:1332447 6480464 AHR protein affects the reaction [Benzo(a)pyrene affects the expression of FCGR2B mRNA] CTD PMID:22228805 benzo[a]pyrene decreases expression ISO RGD:1332447 6480464 Benzo(a)pyrene results in decreased expression of FCGR2B mRNA CTD PMID:19770486 benzo[a]pyrene increases expression ISO RGD:1332447 6480464 Benzo(a)pyrene results in increased expression of FCGR2B mRNA CTD PMID:22228805 bexarotene multiple interactions EXP 6480464 [bexarotene co-treated with Tamoxifen] results in decreased expression of FCGR2B mRNA CTD PMID:17630414 bis(2-chloroethyl) sulfide increases expression ISO RGD:1332447 6480464 Mustard Gas results in increased expression of FCGR2B mRNA CTD PMID:15674843 , PMID:18955075 bis(2-ethylhexyl) phthalate decreases expression ISO RGD:1332447 6480464 Diethylhexyl Phthalate results in decreased expression of FCGR2B mRNA CTD PMID:19850644 bis(2-ethylhexyl) phthalate affects expression ISO RGD:1332447 6480464 Diethylhexyl Phthalate affects the expression of FCGR2B mRNA CTD PMID:27405655 bis(2-ethylhexyl) phthalate multiple interactions ISO RGD:1332447 6480464 PPARA protein promotes the reaction [Diethylhexyl Phthalate results in decreased expression of FCGR2B mRNA] CTD PMID:19850644 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of FCGR2B mRNA CTD PMID:25181051 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of FCGR2B mRNA CTD PMID:30903817 bisphenol F increases expression ISO RGD:1332447 6480464 bisphenol F results in increased expression of FCGR2B mRNA CTD PMID:30951980 cadmium atom decreases expression ISO RGD:1346227 6480464 Cadmium results in decreased expression of FCGR2B mRNA CTD PMID:24376830 carbofuran increases expression EXP 6480464 Carbofuran results in increased expression of FCGR2B mRNA CTD PMID:20211217 carbon nanotube increases expression ISO RGD:1332447 6480464 Nanotubes more ... CTD PMID:25554681 carbon nanotube affects expression ISO RGD:1332447 6480464 Nanotubes, Carbon affects the expression of FCGR2B mRNA CTD PMID:23845593 carbonyl sulfide increases expression EXP 6480464 carbonyl sulfide results in increased expression of FCGR2B mRNA CTD PMID:19395590 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of FCGR2B mRNA CTD PMID:18500788 chloroethene decreases expression ISO RGD:1332447 6480464 Vinyl Chloride results in decreased expression of FCGR2B protein CTD PMID:36892438 clofibric acid multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of FCGR2B mRNA CTD PMID:17602206 cocaine decreases expression EXP 6480464 Cocaine results in decreased expression of FCGR2B mRNA CTD PMID:27899881 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of FCGR2B mRNA CTD PMID:27523638 dexamethasone increases expression ISO RGD:1332447 6480464 Dexamethasone results in increased expression of FCGR2B mRNA CTD PMID:21041162 dextran sulfate multiple interactions ISO RGD:1332447 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FCGR2B mRNA CTD PMID:29950665 diclofenac decreases expression ISO RGD:1332447 6480464 Diclofenac results in decreased expression of FCGR2B mRNA CTD PMID:35537566 diethylstilbestrol increases expression ISO RGD:1332447 6480464 Diethylstilbestrol results in increased expression of FCGR2B mRNA CTD PMID:21041162 dioxygen multiple interactions ISO RGD:1332447 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of FCGR2B mRNA CTD PMID:30529165 dioxygen multiple interactions EXP 6480464 [Oxygen deficiency co-treated with Blood Glucose deficiency co-treated with Particulate Matter] results in increased expression of FCGR2B mRNA CTD PMID:33729688 doramapimod decreases expression ISO RGD:1332447 6480464 doramapimod results in decreased expression of FCGR2B mRNA CTD PMID:21328587 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of FCGR2B mRNA CTD PMID:20211217 doxorubicin multiple interactions ISO RGD:1332447 6480464 [[MT1 protein co-treated with MT2 protein] affects the susceptibility to Doxorubicin] which affects the expression of FCGR2B mRNA CTD PMID:21040762 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of FCGR2B mRNA CTD PMID:29391264 epoxiconazole decreases expression ISO RGD:1332447 6480464 epoxiconazole results in decreased expression of FCGR2B mRNA CTD PMID:35436446 ethanol affects expression ISO RGD:1332447 6480464 Ethanol affects the expression of FCGR2B mRNA CTD PMID:26730594 eugenol increases expression ISO RGD:1346227 6480464 Eugenol results in increased expression of FCGR2B mRNA CTD PMID:17374397 fipronil increases expression EXP 6480464 fipronil results in increased expression of FCGR2B mRNA CTD PMID:23962444 formaldehyde increases expression EXP 6480464 Formaldehyde results in increased expression of FCGR2B mRNA CTD PMID:24304932 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of FCGR2B mRNA CTD PMID:22061828 , PMID:33387578 glafenine increases expression EXP 6480464 Glafenine results in increased expression of FCGR2B mRNA CTD PMID:24136188 graphene oxide increases expression ISO RGD:1332447 6480464 graphene oxide analog results in increased expression of FCGR2B mRNA, graphene oxide results in increased expression of FCGR2B mRNA CTD PMID:33227293 irinotecan increases expression EXP 6480464 Irinotecan results in increased expression of FCGR2B mRNA CTD PMID:20097248 isoprenaline increases expression ISO RGD:1332447 6480464 Isoproterenol results in increased expression of FCGR2B mRNA CTD PMID:20003209 isoprenaline increases expression EXP 6480464 Isoproterenol results in increased expression of FCGR2B mRNA CTD PMID:20211217 lipopolysaccharide increases expression ISO RGD:1332447 6480464 Lipopolysaccharides results in increased expression of FCGR2B mRNA CTD PMID:21461237 , PMID:31270303 lipopolysaccharide multiple interactions ISO RGD:1346227 6480464 [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of FCGR2B mRNA more ... CTD PMID:31059760 , PMID:35811015 lipopolysaccharide increases expression ISO RGD:1346227 6480464 Lipopolysaccharides results in increased expression of FCGR2B mRNA CTD PMID:31059760 lipopolysaccharide multiple interactions ISO RGD:1332447 6480464 [IFNG protein co-treated with Lipopolysaccharides] results in increased expression of FCGR2B mRNA more ... CTD PMID:21461237 , PMID:37019307 melatonin multiple interactions ISO RGD:1332447 6480464 Melatonin inhibits the reaction [Lipopolysaccharides results in increased expression of FCGR2B mRNA] CTD PMID:21461237 melatonin decreases expression ISO RGD:1332447 6480464 Melatonin results in decreased expression of FCGR2B mRNA CTD PMID:21461237 menadione affects expression ISO RGD:1332447 6480464 Vitamin K 3 affects the expression of FCGR2B mRNA CTD PMID:20829426 mercury dichloride affects response to substance ISO RGD:1332447 6480464 FCGR2B protein affects the susceptibility to Mercuric Chloride CTD PMID:18314309 methotrexate decreases expression ISO RGD:1346227 6480464 Methotrexate results in decreased expression of FCGR2B mRNA CTD PMID:17400583 methyl methanesulfonate decreases expression ISO RGD:1346227 6480464 Methyl Methanesulfonate results in decreased expression of FCGR2B mRNA CTD PMID:23649840 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of FCGR2B mRNA CTD PMID:31378766 methylmercury chloride increases expression ISO RGD:1332447 6480464 methylmercuric chloride results in increased expression of FCGR2B mRNA CTD PMID:31270303 methylphenidate increases expression ISO RGD:1332447 6480464 Methylphenidate results in increased expression of FCGR2B mRNA CTD PMID:22470460 N-methyl-4-phenylpyridinium increases expression EXP 6480464 1-Methyl-4-phenylpyridinium results in increased expression of FCGR2B mRNA CTD PMID:28801915 N-nitrosodiethylamine multiple interactions EXP 6480464 [Diethylnitrosamine co-treated with Clofibric Acid] affects the expression of FCGR2B mRNA CTD PMID:17602206 nickel atom increases expression ISO RGD:1346227 6480464 Nickel results in increased expression of FCGR2B mRNA CTD PMID:24768652 , PMID:25583101 nickel sulfate increases expression ISO RGD:1346227 6480464 nickel sulfate results in increased expression of FCGR2B mRNA CTD PMID:17374397 ozone multiple interactions ISO RGD:1332447 6480464 [Air Pollutants results in increased abundance of [Ozone co-treated with Soot]] which affects the expression of FCGR2B mRNA, [Air Pollutants results in increased abundance of Ozone] which results in increased expression of FCGR2B mRNA CTD PMID:34911549 paclitaxel increases expression EXP 6480464 Paclitaxel results in increased expression of FCGR2B mRNA CTD PMID:18754875 paracetamol affects expression ISO RGD:1332447 6480464 Acetaminophen affects the expression of FCGR2B mRNA CTD PMID:17562736 paracetamol multiple interactions ISO RGD:1346227 6480464 [Acetaminophen co-treated with Lipopolysaccharides] results in decreased expression of FCGR2B mRNA CTD PMID:31059760 paracetamol decreases expression ISO RGD:1346227 6480464 Acetaminophen results in decreased expression of FCGR2B mRNA CTD PMID:31059760 phenacetin increases expression EXP 6480464 Phenacetin results in increased expression of FCGR2B mRNA CTD PMID:17082564 phenylhydrazine increases expression EXP 6480464 phenylhydrazine results in increased expression of FCGR2B mRNA CTD PMID:17082564 pirinixic acid decreases expression ISO RGD:1332447 6480464 pirinixic acid results in decreased expression of FCGR2B mRNA CTD PMID:18445702 , PMID:20059764 pirinixic acid multiple interactions ISO RGD:1332447 6480464 PPARA protein promotes the reaction [pirinixic acid results in decreased expression of FCGR2B mRNA] CTD PMID:20059764 quartz increases expression EXP 6480464 Quartz results in increased expression of FCGR2B mRNA CTD PMID:19836432 quercetin increases expression ISO RGD:1346227 6480464 Quercetin results in increased expression of FCGR2B mRNA CTD PMID:15309432 S-(1,2-dichlorovinyl)-L-cysteine decreases expression ISO RGD:1346227 6480464 S-(1, 2-dichlorovinyl)cysteine results in decreased expression of FCGR2B mRNA CTD PMID:35811015 S-(1,2-dichlorovinyl)-L-cysteine multiple interactions ISO RGD:1346227 6480464 [S-(1 more ... CTD PMID:35811015 S-nitroso-N-acetyl-D-penicillamine decreases expression EXP 6480464 S-Nitroso-N-Acetylpenicillamine results in decreased expression of FCGR2B mRNA CTD PMID:12102619 SCH 23390 multiple interactions ISO RGD:1332447 6480464 SCH 23390 inhibits the reaction [1-(2-thienyl)-2-(methylamino)propane results in increased expression of FCGR2B mRNA] CTD PMID:30922767 silicon dioxide decreases expression ISO RGD:1346227 6480464 Silicon Dioxide analog results in decreased expression of FCGR2B mRNA CTD PMID:25895662 silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of FCGR2B mRNA CTD PMID:22431001 , PMID:32721576 Soman increases expression EXP 6480464 Soman results in increased expression of FCGR2B mRNA CTD PMID:19281266 sulpiride multiple interactions ISO RGD:1332447 6480464 Sulpiride inhibits the reaction [1-(2-thienyl)-2-(methylamino)propane results in increased expression of FCGR2B mRNA] CTD PMID:30922767 T-2 toxin increases expression EXP 6480464 T-2 Toxin results in increased expression of FCGR2B mRNA CTD PMID:26141394 tamibarotene affects expression ISO RGD:1346227 6480464 tamibarotene affects the expression of FCGR2B mRNA CTD PMID:15498508 tamoxifen multiple interactions EXP 6480464 [bexarotene co-treated with Tamoxifen] results in decreased expression of FCGR2B mRNA CTD PMID:17630414 testosterone multiple interactions EXP 6480464 [estradiol 3-benzoate co-treated with [Testosterone co-treated with Estradiol]] results in increased expression of FCGR2B mRNA CTD PMID:32741896 tetrachloromethane affects expression EXP 6480464 Carbon Tetrachloride affects the expression of FCGR2B mRNA CTD PMID:12734012 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of FCGR2B mRNA CTD PMID:34492290 titanium dioxide increases expression ISO RGD:1332447 6480464 titanium dioxide results in increased expression of FCGR2B mRNA CTD PMID:19464567 , PMID:23557971 titanium dioxide multiple interactions ISO RGD:1332447 6480464 [titanium dioxide co-treated with Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of FCGR2B mRNA CTD PMID:29950665 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of FCGR2B mRNA CTD PMID:30012374 titanium dioxide decreases expression ISO RGD:1332447 6480464 titanium dioxide results in decreased expression of FCGR2B mRNA CTD PMID:29264374 tremolite asbestos increases expression ISO RGD:1332447 6480464 tremolite results in increased expression of FCGR2B mRNA CTD PMID:29279043 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of FCGR2B mRNA CTD PMID:33387578 trimellitic anhydride increases expression ISO RGD:1332447 6480464 trimellitic anhydride results in increased expression of FCGR2B mRNA CTD PMID:19042947 troglitazone increases expression ISO RGD:1332447 6480464 Troglitazone results in increased expression of FCGR2B mRNA CTD PMID:28973697 trovafloxacin decreases expression ISO RGD:1332447 6480464 trovafloxacin results in decreased expression of FCGR2B mRNA CTD PMID:35537566 undecane increases expression EXP 6480464 undecane results in increased expression of FCGR2B protein CTD PMID:17337753 ursolic acid multiple interactions ISO RGD:1332447 6480464 ursolic acid inhibits the reaction [[IFNG protein co-treated with Lipopolysaccharides] results in increased expression of FCGR2B mRNA] CTD PMID:37019307 valproic acid decreases methylation ISO RGD:1346227 6480464 Valproic Acid results in decreased methylation of FCGR2B gene CTD PMID:29154799 vincaleukoblastine increases expression EXP 6480464 Vinblastine results in increased expression of FCGR2B mRNA CTD PMID:20624997 vinclozolin increases expression EXP 6480464 vinclozolin results in increased expression of FCGR2B mRNA CTD PMID:23034163 vinclozolin decreases methylation EXP 6480464 vinclozolin results in decreased methylation of FCGR2B gene CTD PMID:30207508 vincristine increases expression EXP 6480464 Vincristine results in increased expression of FCGR2B mRNA CTD PMID:20624997
